Subject(s)
Coronavirus Infections , Disclosure , Infection Control , Pandemics , Pneumonia, Viral , Politics , Public Policy , Betacoronavirus , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Coronavirus Infections/transmission , Decision Making , Humans , Infection Control/methods , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , Pneumonia, Viral/transmission , Quarantine , SARS-CoV-2 , Time Factors , United States/epidemiologySubject(s)
Coronavirus Infections , Critical Care/organization & administration , Delivery of Health Care/organization & administration , Epidemics , Health Workforce , Pneumonia, Viral , State Medicine/organization & administration , Betacoronavirus , COVID-19 , Coronavirus Infections/diagnosis , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Equipment and Supplies, Hospital , Hospitals , Humans , Pneumonia, Viral/diagnosis , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , SARS-CoV-2 , United Kingdom/epidemiologySubject(s)
Coronavirus Infections/epidemiology , Pandemics/statistics & numerical data , Pneumonia, Viral/epidemiology , COVID-19 , Caribbean Region/epidemiology , Central America/epidemiology , Chile/epidemiology , Comorbidity , Coronavirus Infections/prevention & control , Humans , Latin America/epidemiology , Mexico/epidemiology , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Politics , PovertySubject(s)
Abattoirs , Coronavirus Infections/epidemiology , Meat-Packing Industry , Pneumonia, Viral/epidemiology , Betacoronavirus , COVID-19 , Communicable Disease Control/methods , Coronavirus Infections/prevention & control , Humans , Occupational Exposure , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , SARS-CoV-2Subject(s)
Coronavirus Infections , Decision Making , Health Planning , Health Policy , International Cooperation , Pandemics , Pneumonia, Viral , Betacoronavirus , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Europe/epidemiology , European Union , Ezetimibe, Simvastatin Drug Combination , Forecasting , Guidelines as Topic , Humans , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , SARS-CoV-2 , Time Factors , United KingdomSubject(s)
Coronavirus Infections/prevention & control , Pandemics/prevention & control , Personal Protective Equipment/supply & distribution , Pneumonia, Viral/prevention & control , Purchasing, Hospital/statistics & numerical data , Betacoronavirus/isolation & purification , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/mortality , Coronavirus Infections/virology , England/epidemiology , Equipment and Supplies, Hospital/statistics & numerical data , Equipment and Supplies, Hospital/supply & distribution , Government Employees/legislation & jurisprudence , Humans , Personal Protective Equipment/trends , Pneumonia, Viral/epidemiology , Pneumonia, Viral/mortality , Pneumonia, Viral/virology , SARS-CoV-2 , State Medicine/organization & administrationSubject(s)
Coronavirus Infections , Masks , Pandemics , Pneumonia, Viral , Public Health , Betacoronavirus , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Coronavirus Infections/transmission , Evidence-Based Medicine , Guidelines as Topic , Humans , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , Pneumonia, Viral/transmission , Review Literature as Topic , SARS-CoV-2Subject(s)
Allergy and Immunology/trends , Animals, Domestic/immunology , Animals, Wild/immunology , Communicable Diseases, Emerging/immunology , Communicable Diseases, Emerging/prevention & control , Ecosystem , Animals , COVID-19 , Chiroptera , Communicable Diseases, Emerging/veterinary , Coronavirus Infections/immunology , Coronavirus Infections/prevention & control , Coronavirus Infections/veterinary , Disease Models, Animal , Humans , Immune System , Pandemics/prevention & control , Pandemics/veterinary , Pneumonia, Viral/immunology , Pneumonia, Viral/prevention & control , Pneumonia, Viral/veterinarySubject(s)
Coronavirus Infections/prevention & control , Disclosure , Health Personnel , Pandemics/prevention & control , Personal Protective Equipment/supply & distribution , Pneumonia, Viral/prevention & control , Betacoronavirus , COVID-19 , Coronavirus Infections/transmission , Health Resources , Humans , Pneumonia, Viral/transmission , Practice Guidelines as Topic , SARS-CoV-2Subject(s)
Breast Feeding , Coronavirus Infections , Infection Control/methods , Milk, Human , Pandemics , Pneumonia, Viral , Pregnancy Complications, Infectious , Psychosocial Support Systems , Betacoronavirus/immunology , Betacoronavirus/isolation & purification , Breast Feeding/methods , Breast Feeding/psychology , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Coronavirus Infections/transmission , Female , Humans , Infant, Newborn , Infectious Disease Transmission, Vertical/prevention & control , Male , Milk, Human/immunology , Milk, Human/virology , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , Pneumonia, Viral/transmission , Postnatal Care/methods , Postnatal Care/trends , Pregnancy , Pregnancy Complications, Infectious/epidemiology , Pregnancy Complications, Infectious/prevention & control , SARS-CoV-2 , United StatesABSTRACT
A novel coronavirus (severe acute respiratory syndrome-CoV-2) that initially originated from Wuhan, China, in December 2019 has already caused a pandemic. While this novel coronavirus disease (COVID-19) frequently induces mild diseases, it has also generated severe diseases among certain populations, including older-aged individuals with underlying diseases, such as cardiovascular disease and diabetes. As of 31 March 2020, a total of 9786 confirmed cases with COVID-19 have been reported in South Korea. South Korea has the highest diagnostic rate for COVID-19, which has been the major contributor in overcoming this outbreak. We are trying to reduce the reproduction number of COVID-19 to less than one and eventually succeed in controlling this outbreak using methods such as contact tracing, quarantine, testing, isolation, social distancing and school closure. This report aimed to describe the current situation of COVID-19 in South Korea and our response to this outbreak.
Subject(s)
Betacoronavirus/pathogenicity , COVID-19/epidemiology , COVID-19/transmission , Communicable Disease Control/organization & administration , Coronavirus Infections/epidemiology , Coronavirus Infections/transmission , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/transmission , Quarantine/organization & administration , Basic Reproduction Number , COVID-19/prevention & control , Coronavirus Infections/prevention & control , Epidemiological Monitoring , Evidence-Based Medicine , Human Activities , Humans , Physical Distancing , Pneumonia, Viral/prevention & control , Republic of Korea/epidemiology , SARS-CoV-2 , TravelSubject(s)
Coronavirus Infections , Drug Repositioning , Pandemics , Pneumonia, Viral , Viral Vaccines , Betacoronavirus , COVID-19 , COVID-19 Vaccines , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Drug Design , Drug Discovery , Humans , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , SARS-CoV-2 , Spike Glycoprotein, Coronavirus/drug effectsSubject(s)
Betacoronavirus , Civil Defense , Coronavirus Infections , Internationality , Pandemics , Pneumonia, Viral , Public Health , Public Policy , Asia , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Disaster Planning , Humans , Hygiene , Information Dissemination , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , Politics , Quarantine , Risk , SARS-CoV-2 , TravelSubject(s)
Communicable Disease Control/trends , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Occupational Health , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , COVID-19 , Elective Surgical Procedures/statistics & numerical data , Female , Hospitalization/statistics & numerical data , Humans , Iran , Male , Practice Patterns, Physicians' , Risk Assessment , Urologic Neoplasms/surgery , Urologists/statistics & numerical dataSubject(s)
Coronavirus Infections/prevention & control , Equipment Reuse , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Respiratory Protective Devices , Smoke , Betacoronavirus , COVID-19 , Cholangiopancreatography, Endoscopic Retrograde , Choledocholithiasis/surgery , Coronavirus Infections/transmission , Humans , Particle Size , Pneumonia, Viral/transmission , SARS-CoV-2 , Smell , Sphincterotomy, EndoscopicABSTRACT
It has been more than 2 months since the outbreak of coronavirus diseaseï¼COVID-19ï¼. The Chinese Ear & Nose & Throat Departmentï¼ENTï¼ health care workers are brave in defending against the disease. The COVID-19 patients without predominant symptoms may consult ENT doctors, even though the ENT department isn't thought first front of the battle. The ENT health care workers have high risks of exposing to the SARS-CoV-2 virus. This article gives some recommendations of infection prevention and control to ENT health care workers of the outpatient and inpatient department.